Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice.

BACKGROUND: Alcoholic liver disease (ALD) is responsible for 3.3 million deaths per annum. Efficacious therapeutic modalities or drug treatments for ALD have not yet been found, so it is urgent to seek new agents for preventing ALD and its related disease. Many experiments have indicated that modulating the gut microbiota and regulating the toll-like receptor 4 (TLR4)/nuclear transcription factor-κB (NF-κB) inflammatory pathway can provide a new target for prevention and treatment of ALD. Marine microalgae have their natural metabolic pathways to synthesize various of bioactive compounds as promising candidates for hepatoprotection. In this study, we investigated ethanol extracts from Isochrysis zhanjiangensis (EEIZ) to evaluate their ability to alleviate acute alcoholic liver injury, regulate TLR4/NF-κB inflammatory pathway and modulate intestinal bacteria dysbiosis in mice for ALD treatment. RESULTS: In the acute ALD mouse model, EEIZ reduced levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, triacylglyceride, total cholesterol and low-density lipoprotein, while increasing the level of high-density lipoprotein. Besides, TLR4, myeloid differentiation factor 88, NF-κB and tumor necrosis factor-α expression levels in liver tissue were effectively downregulated by EEIZ. Furthermore, treatment with EEIZ enhanced intestinal homeostasis and significantly alleviated the damage caused by alcohol. CONCLUSION: EEIZ showed effective hepatoprotective activity against alcohol-induced acute liver injury in mice as it could alleviate hepatocyte damage, suppress the TLR4/NF-κB inflammatory pathway and regulate the intestinal flora structure. EEIZ could be a good candidate for preventing acute alcoholic liver injury. © 2024 Society of Chemical Industry.

No evidence of coronary plaque stabilization by allopurinol in patients with acute coronary syndrome.

BACKGROUND: Allopurinol, a xanthine inhibitor that lowers uric acid concentration, has been proven to reduce inflammation and oxidative stress in patients with cardiovascular disease. However, it is unknown whether these beneficial effects translate into favorable plaque modification in acute coronary syndromes (ACS). This study aimed to investigate whether allopurinol could improve coronary plaque stabilization using coronary computed tomography angiography (CCTA). METHODS: This was a prospective, single-center, randomized, double-blind clinical trial began in March 2019. A total of 162 ACS patients aged 18-80 years with a blood level of high-sensitivity C-reactive protein (hsCRP) â€‹> â€‹2 â€‹mg/L were included. The subjects were randomly assigned in a 1:1 ratio to receive either allopurinol sustained-release capsules (at a dose of 0.25 â€‹g once daily) or placebo for 12 months. The plaque analysis was performed at CCTA. The primary efficacy endpoint was the change in low-attenuation plaque volume (LAPV) from baseline to the 12-month follow-up. RESULTS: Among 162 patients, 54 in allopurinol group and 51 in placebo group completed the study. The median follow-up duration was 14 months in both groups. Compared with placebo, allopurinol therapy did not significantly alter LAPV (-13.4 â€‹± â€‹3.7 â€‹% vs. -17.8 â€‹± â€‹3.6 â€‹%, p â€‹= â€‹0.390), intermediate attenuation plaque volume (-16.1 â€‹± â€‹3.0 â€‹% vs. -16.2 â€‹± â€‹2.9 â€‹%, p â€‹= â€‹0.992), dense calcified plaque volume (12.2 â€‹± â€‹13.7 â€‹% vs. 9.7 â€‹± â€‹13.0 â€‹%, p â€‹= â€‹0.894), total atheroma volume (-15.2 â€‹± â€‹3.2 â€‹% vs. -16.4 â€‹± â€‹3.1 â€‹%, p â€‹= â€‹0.785), remodeling index (2.0 â€‹± â€‹3.9 â€‹% vs. 5.4 â€‹± â€‹3.8 â€‹%, p â€‹= â€‹0.536) or hsCRP levels (-73.6 [-91.6-17.9] % vs. -81.2 [-95.4-47.7] %, p â€‹= â€‹0.286). CONCLUSIONS: Our findings suggest that allopurinol does not improve atherosclerotic plaque stability or inflammation in ACS.

Real-time response counterattack strategy of tolerant microalgae Chlorella vulgaris MBFJNU-1 in original swine wastewater and free ammonia.

This work was the first time to systematically clarify the potential tolerance mechanism of an indigenous Chlorella vulgaris MBFJNU-1 towards the free ammonia (FA) during the original swine wastewater (OSW) treatment by transcriptome analysis using C. vulgaris UETX395 as the control group. The obtained results showed that C. vulgaris MBFJNU-1 was found to be more resistant to the high levels of FA (115 mg/L) and OSW in comparison to C. vulgaris UETX395 (38 mg/L). Moreover, the transcriptomic results stated that some key pathways from arginine biosynthesis, electron generation and transmission, ATP synthesis in chloroplasts, and glutathione synthesis of C. vulgaris MBFJNU-1 were greatly related with the OSW and FA. Additionally, C. vulgaris MBFJNU-1 in OSW and FA performed similar results in the common differentially expressed genes from these mentioned pathways. Overall, these obtained results deliver essential details in microalgal biotechnology to treat swine wastewater and high free ammonia wastewater.

Pilot-scale remediation of rare earth elements ammonium wastewater by Chlamydomonas sp. YC in summer under outdoor conditions.

This work evaluated the performance of real rare earth elements (REEs) wastewater purification and carbon dioxide (CO2) fixation by Chlamydomonas sp. YC with pilot-scale airlift-photobioreactors (AL-PBRs), tubular photobioreactors (TB-PBRs) and raceway ponds (ORWPs) under high-temperature outdoor conditions in summer. The obtained results showed that Chlamydomonas sp. YC at 1 g/L oyster shell piece (OSP) and 3 % CO2 had the highest biomass (1.9 g/L) and NH4+-N removal efficiency (34.0 %) during the REEs wastewater treatment. Among the selected photobioreactors, Chlamydomonas sp. YC to treat real REEs wastewater at 3 % CO2 under high-temperature outdoor conditions attained the highest biomass (2.3 g/L) in the TB-PBRs with the best NH4+-N removal efficiency (43.0 %). Furthermore, the input cost and CO2 net sequestration evaluation revealed that TB-PBRs was more economical photobioreactors to treat REEs wastewater and fix CO2 by Chlamydomonas sp. YC, providing some vital scientific details for REEs wastewater and CO2 fixation by microalgal biotechnology.

A novel very small granular starch from Chlorella sp. MBFJNU-17.

Novel resources of very small granular starch are of great interests to food scientists. We previously found Chlorella sp. MBFJNU-17 contained small granular starch but whether the MBFJNU-17 was a novel resource of very small granular starch remained unresolved. This study isolated and characterized the starch from MBFJNU-17 in comparison with quinoa starch (a typical very small granular starch), and discussed whether the MBFJNU-17 could be a resource of very small granular starch. Results showed that chlorella starch displayed a smaller size (1024 nm) than quinoa starch did (1107 nm), suggesting MBFJNU-17 was a good resource of very small granular starch. Additionally, chlorella starch had less amylose, higher proportion of long amylopectin branches, more ordered structures, thinner amorphous lamellae, better paste thermostability, and slower enzymatic digestion than quinoa starch did. These findings indicated that Chlorella sp. MBFJNU-17 was a novel resource of very small granular starch with desirable thermostability and nutritional attributes.

A newly isolated microalga Chlamydomonas sp. YC to efficiently remove ammonium nitrogen of rare earth elements wastewater.

The aim of this study was to establish a practical approach to remove ammonium nitrogen of rare earth elements (REEs) wastewater by an indigenous photoautotrophic microalga. Firstly, a new microalgal strain was successfully isolated from REEs wastewater and identified as Chlamydomonas sp. (named Chlamydomonas sp. YC). The obtained results showed that microalga could completely remove the NH4+-N of 10% REEs wastewater after 10 days of cultivation; however, the highest NH4+-N removal rate was attained by microalga to treat undiluted REEs wastewater. Then, three cultivation modes including batch, semi-continuous and continuous cultivation methods were developed to evaluate the ability of NH4+-N removal rate by this microalga to treat diluted (10%) and undiluted REEs wastewater. It was found that, Chlamydomonas sp. YC exhibited superior performance towards NH4+-N removal rates (32.75-61.05 mg/(L·d)) by semi-continuous and continuous processes for the treatments of 10% and undiluted REEs wastewater in comparison to the results (19.50-30.38 mg/(L·d) by batch process. Interestingly, under the same treatment conditions, among the three cultivation modes, microalga exhibited the highest removal rates of NH4+-N in undiluted REEs wastewater by semi-continuous (61.05 mg/(L·d)) and continuous (57.10 mg/(L·d) processes. In term of the biochemical analysis, microalgal biomass obtained from the wastewater treatment had 35.40-44.40% carbohydrate and 4.97-6.03% lipid, which could be potential ingredients for sustainable biofuels production. And the highest carbohydrate and lipid productivities attained by Chlamydomonas sp. YC in the continuous mode were 226.36 mg/(L·d) and 32.98 mg/(L·d), respectively. Taken together, the established processes mediated with Chlamydomonas sp. YC via continuous cultivation was the great promising approaches to efficiently remove NH4+-N of REEs wastewater and produce valuable biomass for sustainable and renewable biofuels in a simultaneous manner.

Chlorella vulgaris cultivation in pilot-scale to treat real swine wastewater and mitigate carbon dioxide for sustainable biodiesel production by direct enzymatic transesterification.

This study firstly addressed real swine wastewater (RSW) treatment by an indigenous Chlorella vulgaris MBFJNU-1 in 5-m3 outdoor open raceway ponds and then direct enzymatic transesterification of the resulting lipids from the wet biomass for sustainable biodiesel production. Compared to the control group, C. vulgaris MBFJNU-1 at 3% CO2 achieved higher microalgal biomass (478.5 mg/L) and total fatty acids content (21.3%), higher CO2 bio-fixation (63.2 mg/L/d) and lipid (9.1 mg/L/d) productivities, and greater nutrients removals (total nitrogen, 82.1%; total phosphorus, 28.4%; chemical oxygen demand, 37.1%). The highest biodiesel conversion (93.3%) was attained by enzymatic transesterification of wet disrupted Chlorella biomass with 5% lipase TL and 5% phospholipase PLA. Moreover, the enzymatic transesterification gave around 83% biodiesel conversion in a 15-L stirred tank bioreactor. Furthermore, the integrated process was a cost-effective approach to treat RSW and mitigate CO2 for microalgal biodiesel production, based on the mass and energy balances analysis.

A novel two-stage heterotrophic cultivation for starch-to-protein switch to efficiently enhance protein content of Chlorella sp. MBFJNU-17.

This work aimed to firstly establish an efficient and novel two-stage cultivation process to produce microalgal biomass rich in protein using a heterotrophic Chlorella sp. MBFJNU-17 strain. In the first-stage cultivation, to reduce the glucose and urea utilization, microalga achieved a high biomass at 40 g/L glucose and 1 g/L urea; meantime, the expression from starch biosynthesis genes of microalga was up-regulated under nitrogen-starvation conditions for starch accumulation (55.01%). In the second-stage cultivation, based on the over-compensation effect, Chlorella cells after the first-stage cultivation were further treated at 5 g/L glucose and 3 g/L urea to up-regulate starch degradation, central carbon metabolism and urea absorption genes expression to drive intracellular starch-to-protein switch for biosynthetic protein (59.75%). Moreover, microalga performed similar characteristics in a 10-L fermenter by the established process. Taken together, Chlorella sp. MBFJNU-17 was the promising candidate to produce high-value biomass enriched in protein by the established two-stage cultivation.

A novel and efficient strategy mediated with calcium carbonate-rich sources to remove ammonium sulfate from rare earth wastewater by heterotrophic Chlorella species.

This work was the first time to establish the desired approach with two heterotrophic Chlorella species for ammonium sulfate (AS)-rich rare earth elements (REEs) wastewater treatment by heterotrophic cultivation. The results showed that these two Chlorella species treated by 6 g/L CaCO3 performed the best ability to remove NH4+-N and SO42- of REEs wastewater. Moreover, the established process performed similar features in REEs wastewater treatment by replacing CaCO3 with eggshell powder (ESP) and oyster shell powder (OSP) enriched in CaCO3. Furthermore, microalgae treated by ESP/OSP in a 10-L fermenter showed 837.39 mg/(L·d) NH4+-N and 1,820 mg/(L·d) SO42- removal rates. The developed kinetic models could be well fitted to the experimental data obtained by the 10-L fermenter. Taken together, the established process mediated with two Chlorella species and ESP/OSP by heterotrophic cultivation was the great potential for AS-rich REEs wastewater treatment in a cost-effective manner.

Isolation of an indigenous Chlorella vulgaris from swine wastewater and characterization of its nutrient removal ability in undiluted sewage.

Bio-treatment of wastewater mediated by microalgae is considered as a promising solution. This work aimed to isolate an indigenous microalgal strain (named MBFJNU-1) from swine wastewater effluent and identify as Chlorella vulgaris. After 12days, the removal efficiencies of total nitrogen (TN) and total phosphorus (TP) in undiluted swine slurry were 90.51% and 91.54%, respectively. Stress tolerance in response to wastewater was verified by cultivating in artificial wastewater containing different levels of chemical oxygen demand (COD), TN and TP. MBFJNU-1 could grow well in undiluted swine slurry and artificial wastewater containing 30,000mg/L COD or 2000mg/L TN. Furthermore, global nuclear DNA methylation (5-mC) of MBFJNU-1 was employed to explore the possible mechanism in response to wastewater stress. The results showed that the level of 5-mC was inversely proportional to the growth of MBFJNU-1 in different diluted swine slurry, helping to understand 5-mC variation in response to stress environment.

[Determination of antioxidants in plasma and erythrocyte in patients with epilepsy].

OBJECTIVE: To explore the changes of antioxidants in plasma and erythrocyte in epileptic patients. METHODS: The levels of erythrocyte enzymes glutathione reductase (GR), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase and erythrocyte membrane lipid peroxidation (MDA), the percentage hemolysis, and plasma ceruloplasmin, vitamin A, vitamin C, vitamin E were measured in 39 controls, 32 epileptic patients and 26 follow-up patients. RESULTS: The levels of MDA, the percentage hemolysis, GSH-Px, CAT and plasma CER in the epileptic patients were significantly higher than those of the controls. While the levels of vitamin A, vitamin C, vitamin E, SOD and GR in the epileptic patients were markedly lower than those of controls. In the follow-up patients, the levels of GR, SOD, vitamin C and vitamin E were significantly higher than those of the epileptic patients. CONCLUSION: Free radicals and antioxidants play important roles in the etiology of epilepsy.